Call for Abstract

18th World Pharma Congress, will be organized around the theme “Challenges and Opportunities in Transforming the Pharma Industry”

Pharma Congress 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Congress 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmacology the science that deals with the origin, nature, chemistry, effects and uses of drugs; it includes pharmacognosy, pharmacokinetics, pharmacodynamics, pharmacotherapeutics and toxicology. The various aspects of pharmacological sciences are Behavioural pharmacology, Medical Pharmacology, Cardiovascular pharmacology, Endocrine pharmacology, Clinical pharmacology, Urogenital pharmacology, Pharmacokinetics, Neuropharmacology, Immune pharmacology, Cognitive models of the brain, Neural models of memory, Functional modes of the brain, Neuropsychology, Cognitive neuroscience and neurosystems. Clinical pharmacology

 

  • Track 1-1Neuropharmacology
  • Track 1-2Pharmacokinetics
  • Track 1-3Pharmacodynamics
  • Track 1-4Dental pharmacology
  • Track 1-5Environmental pharmacology
  • Track 1-6Theoretical pharmacology
  • Track 1-7Toxicology
  • Track 1-8Systems pharmacology
  • Track 1-9Pharmacoepidemiology
  • Track 1-10Pharmacogenomics
  • Track 1-11Pharmacogenetics
  • Track 1-12Cardiovascular pharmacology
  • Track 1-13Psychopharmacology
  • Track 1-14Postmarketing drug safety

Pharmacognosy is the study of drugs derived from Plants and herbs and the other aspect of Pharmacognosy is Phytochemistry. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, molecular simulation, and exploratory development and Biochemistry.

 

  • Track 2-1Drugs from natural sources
  • Track 2-2Computational chemistry
  • Track 2-3Structure aided and computer aided drug design
  • Track 2-4Molecular drug design
  • Track 2-5Telemedicine

Pharmaceutical Chemistry the study of drug design to optimize pharmacokinetics and pharmacodynamics, and synthesis of new drug molecules (Medicinal Chemistry). Pharmaceutical Chemistry is a branch of chemistry that deals with the chemical, biochemical and pharmacological aspects of drugs. It includes synthesis/isolation, identification, structural elucidation, structural modification, structural activity relationship (SAR) studies, study of the chemical characteristics, biochemical changes after drug administration and their pharmacological effects as well as analysis of drugs. In more simple words it is more broader than medicinal chemistry in its application also in the fields of analysis, identification, as well as, structural elucidation of drugs

 

  • Track 3-1Drug discovery
  • Track 3-2Protein structure prediction and molecular simulation
  • Track 3-3Biochemistry
  • Track 3-4Exploratory development
  • Track 3-5Phytotherapy & complementary medicine
  • Track 3-6Protein structure prediction and molecular simulation

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of this protein-based therapeutics have also been developed

 

  • Track 4-1Factors influencing drug targeting
  • Track 4-2Advances in drug targeting components
  • Track 4-3Recent approaches to drug targeting
  • Track 4-4Rational drug design
  • Track 4-5Computer aided drug design
  • Track 4-6Drug design theory
  • Track 4-7Role of computers in drug design: Their success and failure
  • Track 4-8Rational drug design software
  • Track 4-9RACHEL software package

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form

  • Track 5-1Formulation types
  • Track 5-2Enteral formulations
  • Track 5-3Parenteral formulations
  • Track 5-4Topical formulations

Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others

 

  • Track 6-1Formulation and pre-formulation development
  • Track 6-2Powder blending
  • Track 6-3Milling
  • Track 6-4Granulation
  • Track 6-5Hot melt extrusion

Sometimes called, molecular manufacturing is a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter. Nanotechnology is also being applied to or developed for application to a variety of industrial and purification processes. Purification and environmental clean-up applications include the desalination of water, water filtration, wastewater treatment, groundwater treatment, and other Nano remediation.

 

  • Track 7-1Nanobiomaterials and biopharmaceuticals
  • Track 7-2Bionanotechnology and BioMEMS
  • Track 7-3Pharmaceutical engineering
  • Track 7-4Nanotechnology in cancer research
  • Track 7-5Nanomedicines
  • Track 7-6Nanotechnology in medicine and in targeted drug delivery
  • Track 7-7Nanotechnology in medicine and drug delivery imaging
  • Track 7-8Nanotechnology and clinical applications
  • Track 7-9Nanotechnology and clinical applications
  • Track 7-10Nano-drugs
  • Track 7-11Nano-mechanisms for molecular Systems

Drug delivery is the process of administering the drug or pharmaceutical product, in order to achieve desired therapeutic effect. The method by which drug delivered is important, as it has significant effect on its efficacy. Novel drug delivery system involves various approaches like medical devices or drug-device combination products. Novel drug delivery system (NDDS) involves combining polymer science, pharmaceutics and molecular biology. Novel drug delivery systems are designed based on physical and biochemical mechanisms. Physical mechanism or controlled drug delivery system includes dissolution, osmosis, erosion and diffusion. Biochemical mechanism includes gene therapy, liposomes, nanoparticles, monoclonal antibodies. NDDS drugs are designed to target the site specific region, in order to achieve desired therapeutic effect, thereby reducing the side or toxic effects. Various drug delivery and drug targeted systems are developed, in order to minimize drug degradation, drug adverse effect, and in order to increase the drug bioavailability (amount of drug available at site targeted region). Site specific drug delivery may be either active or passive process.

  • Track 8-1Micelles
  • Track 8-2Microspheres
  • Track 8-3Erythrocytes
  • Track 8-4Phonophoresis
  • Track 8-5Iontophoresis
  • Track 8-6Fast dissolving tablets (FDT)
  • Track 8-7Hydrogels
  • Track 8-8Nano particles
  • Track 8-9Dendrimers
  • Track 8-10Liposomes
  • Track 8-11Magnetic microparticles

Nanomedicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

 

  • Track 9-1Scope of nanomedicine
  • Track 9-2Novel drugs to nano drugs
  • Track 9-3Nanomedicine for other disease
  • Track 9-4Nanomedicine for gastrointestinal tract (GI) diseases
  • Track 9-5Nanomedicine for gastrointestinal tract (GI) diseases
  • Track 9-6Nanomedicine for CNS
  • Track 9-7Nanomedicine for blood disorders
  • Track 9-8Nanomedicine for lung diseases
  • Track 9-9Nanomedicine for cardiovascular diseases
  • Track 9-10Future aspects of nanomedicine
  • Track 9-11Nanodrugs for herbal medicines and cosmetics

Regulatory Affairs has a very specific meaning within the healthcare industries. Its regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation. The global regulatory affairs outsourcing market had a valuation of US$1.9 bn in 2014. The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

  • Track 10-1Novel approaches to analytical and bioanalytical methods
  • Track 10-2Bioanalytical techniques
  • Track 10-3Chromatography and techniques
  • Track 10-4Spectroscopic techniques
  • Track 10-5Nuclear magnetic resonanace
  • Track 10-6Mass spectroscopy
  • Track 10-7Regulatory issues and biosafety challenges in bioanalysis
  • Track 10-8Applications of analytical and bioanalytical methods

Biologics are medicines made from living cells through highly complex manufacturing processes and must be handled and administered under carefully monitored conditions. Biologics are used to prevent, treat, diagnose, or cure a variety of diseases including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. A biosimilar is exactly what its name implies — it is a biologic that is “similar” to another biologic drug already approved by the FDA. Under U.S. law, a biosimilar is approved based on a showing that it is “highly similar” to an FDA-approved biological product, known as a reference product. It may not have any clinically meaningful differences in terms of safety and effectiveness from the reference product.

 

  • Track 11-1Bio-analytics for biosimilars
  • Track 11-2Extrapolation and Interchangeability
  • Track 11-3Legal considerations for biosimilars
  • Track 11-4Biosimilar uptake and market considerations
  • Track 11-5Challenges and regulatory approach for biosimilars
  • Track 11-6Future of next generation biosimilars

Bio Pharmaceutics plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery,  Sustained drug delivery system, Routes of administration, Fundamental drug development.

 

  • Track 12-1Biopharmaceutics and drug disposition
  • Track 12-2Pharmaceutical technology
  • Track 12-3Innovations in clinical development
  • Track 12-4Pharmaceutics and drug delivery
  • Track 12-5Drug discovery and design
  • Track 12-6Routes of administration
  • Track 12-7Pre formulation studies

Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meager percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago.

 

  • Track 13-1Future of packaging materials
  • Track 13-2Regulatory considerations-China, US, EU, Pharmacopoeia
  • Track 13-3EN 16679-Anti-Counterfeiting and tamper evidence techniques
  • Track 13-4Packaging for patient compliance
  • Track 13-5Packing technology for drug delivery systems
  • Track 13-6Serialization implementation challenges for pharma companies

Quality is always an imperative prerequisite when we consider any product. Therefore, drugs must be manufactured to the highest quality levels. End-product testing by itself does not guarantee the quality of the product. Quality assurance techniques must be used to build the quality into the product at every step and not just tested for at the end. In pharmaceutical industry, Process Validation performs this task to build the quality into the product because according to ISO 9000:2000, it had proven to be an important tool for quality management of pharmaceuticals. Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validation of the individual steps of the processes is called the process validation. Different dosage forms have different validation protocols. Process Validation is one of the important steps in achieving and maintaining the quality of final product. It gives a higher degree of assurance.

 

  • Track 14-1Process validation and drug quality
  • Track 14-2Approach to process validation
  • Track 14-3Statutory and regulatory requirements for process validation
  • Track 14-4Types of process validation
  • Track 14-5Validation protocol and report

Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals e.g. minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial biproducts like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile. Other aspects of pharmaceutical microbiology include the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.

 

  • Track 15-1Antimicrobial effectiveness testing
  • Track 15-2Environmental monitoring
  • Track 15-3Bioburden estimation for medical devices
  • Track 15-4Antibiotic potency testing
  • Track 15-5Particulate matter
  • Track 15-6Bacterial endotoxin testing
  • Track 15-7Investigating USP sterility testing failure
  • Track 15-8Sterility testing
  • Track 15-9Microbial examination of non-sterile products
  • Track 15-10Rapid screening methods

Standards of initial education and training for pharmacists set out the criteria against which we will approve education and training for student pharmacists and pre-registration trainee pharmacists. The standards ensure that newly registered pharmacists are competent to practice safely and effectively. The mission of pharmacy education is to prepare graduates who provide patient centered care that ensures optimal medication therapy outcomes and provides a foundation for specialization in specific areas of pharmacy practice; to participate in the education of patients, other health care providers and future pharmacists, to conduct research and scholarly activity and to provide service and leadership to the community.

 

  • Track 16-1Clinical practice guidelines
  • Track 16-2Patient centered pharmacy practice
  • Track 16-3Global technical standards
  • Track 16-4Critical view of pharmacy education

Industrial pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities. The research topics are focussed on solving current general problems in pharmaceutical industry, such as formulation and characterization of sticky amorphous drugs, problem-solving for paediatric medicines and miniaturization of manufacturing processes.

Physical pharmacy incorporates information of arithmetic, material science and science and applies them to the pharmaceutical dose frame improvement. Physical pharmacy gives the premise to understanding the synthetic and physical wonders that oversee the in vivo and in vitro activities of pharmaceutical items.

 

  • Track 17-1Product management
  • Track 17-2Physical pharmacy practice
  • Track 17-3Post- marketing surveillance
  • Track 17-4Supply chain management
  • Track 17-5Good manufacturing practices
  • Track 17-6Industrial pharmaceutics

Pharmaceutical biotechnology has emerged as one of the major disciplines for drug discovery and development. Today the shape and vision of pharmaceutical aspects and challenges have completely changed, and the prefix "pharma" can also be accepted as a synonym for integrated life science approaches, ranging from genetics to molecular biology to diagnostics, with the common goal of delivering the best drug to the patient by biotechnological techniques.

 

  • Track 18-1Biomedical data engineering
  • Track 18-2Industrial pharma biotechnology
  • Track 18-3Bioinformatics engineering
  • Track 18-4Genetics & genetic engineering
  • Track 18-5Tissue engineering

Clinical pharmacy is a health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, and disease prevention. The practice of clinical pharmacy embraces the philosophy of pharmaceutical care, blending a caring orientation with specialized therapeutic knowledge, experience, and judgment to ensure optimal patient outcomes. As a discipline, clinical pharmacy also has an obligation to contribute to the generation of new knowledge that advances health and quality of life.

Hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapy. The statements were developed by the profession to bring uniformity to the practice of hospital pharmacy.

 

  • Track 19-1Pharmacist key role in treatment
  • Track 19-2Role of clinical pharmacist
  • Track 19-3Challenges in compounding and dispensing pharmacy
  • Track 19-4Role of hospital pharmacists

Pharmacovigilance is the science and exercises identifying with the discovery, evaluation, comprehension and counteractive action of unfavorable impacts or some other pharmaceutical related issue. Pharmacovigilance underpins general wellbeing programs by giving solid data to the productive evaluation of the hazard advantage profile of solutions, add to the appraisal of formal, uses, symptoms, damage, viability and danger of pharmaceuticals, empowering the sheltered, sound and more viable utilization of different medications. Advance instruction, understanding and clinical preparing in Pharmacovigilance and its successful accessibility to people in general.

Drug safety is otherwise called Medication Safety in the field of health. It is related with antagonistic impacts of Pharmaceutical items including numerous other logical perspectives, for example, the reactions of medications, the nature of solutions, prescription mistake in utilization of medications, absence of viability of medications, and fake medications. Tolerant Safety, Drug Interaction (drug–drug and food–drug cooperation) Drug Pharmacokinetic, and Adverse Drug Reaction are a few terms required with Drug Safety.

 

  • Track 20-1Postmarketing drug safety
  • Track 20-2Signal detection in drug safety
  • Track 20-3Consulting on risk management
  • Track 20-4Adverse event reporting

Clinical research aims to advance medical knowledge by studying people, either through direct interaction or through the collection and analysis of blood, tissues, or other samples.

A clinical trial involves research participants. It follows a pre-defined plan or protocol to evaluate the effects of a medical or behavioral intervention on health outcomes. By taking part in clinical trials, participants not only play a more active role in their own health care, but they also can access experimental treatments and help others by contributing to medical research.

 

  • Track 21-1Clinical research & clinical trials: academic perspective
  • Track 21-2Clinical trial forecasting, budgeting and contracting
  • Track 21-3Clinical trial site selection and management
  • Track 21-4CRO, sponsorship & outsourcing for clinical trials
  • Track 21-5Future of clinical trials and technology innovations
  • Track 21-6Clinical data management and analytics
  • Track 21-7Medical imaging in clinical research
  • Track 21-8Clinical trials on different diseases
  • Track 21-9Research and trials on oncology and aids
  • Track 21-10Innovations in clinical study designs
  • Track 21-11Patient-centric clinical trials
  • Track 21-12Clinical operations & project management
  • Track 21-13Clinical supply management

Pharmacogenetics is the science that supports understanding the part that a person's hereditary make-up plays in how well a prescription functions, and additionally what symptoms are probably going to happen, enhancing our capacity to distinguish the hereditary reasons for illnesses and look for new medication targets. Pharmacogenetics alludes to hereditary contrasts in metabolic pathways which can influence singular reactions to drugs, both as far as restorative impact and additionally antagonistic impacts.

Pharmacogenomics is a quickly creating field that has essential ramifications in individualized treatment for patients and its suggestion influence tranquilize advancement issues such as medication safety, efficiency, and customized health care. Pharmacogenomics consolidates customary pharmaceutical sciences, for example, natural chemistry with explained colleague of qualities, proteins, and single nucleotide polymorphisms.

 

  • Track 22-1Cancer pharmcogenetics
  • Track 22-2Recent advances in DNA repair
  • Track 22-3Methods to determine biological targeting
  • Track 22-4T cell modulation and immune response
  • Track 22-5Mutagenecity and genotoxicity

Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the quality assurance in regulatory affairs department.  The importance of intellectual property law is well established at all levels-statutory, administrative and judicial. It lays down minimum standards for protection and enforcement in member countries which are required to promote effective and adequate protection of intellectual property rights with a view to reducing distortions and impediments to international trade. The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.

 

  • Track 23-1Drug regulations and organizations
  • Track 23-2Global pharma products registration
  • Track 23-3Intellectual property law for generics and innovator rights
  • Track 23-4Safety and quality regulation in labelling